Literature DB >> 5067403

Effects of prolonged phenothiazine intake on psychotic and other hospitalized children.

J B McAndrew, Q Case, D A Treffert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5067403     DOI: 10.1007/bf01537628

Source DB:  PubMed          Journal:  J Autism Child Schizophr        ISSN: 0021-9185


× No keyword cloud information.
  32 in total

1.  DRUG-PRODUCED OBESITY. EXPERIENCES WITH CHLORPROMAZINE, PERPHENAZINE AND CLOPENTHIXOL.

Authors:  A AMDISEN
Journal:  Dan Med Bull       Date:  1964-10

2.  [PERSISTENT DYSKINESIA AFTER PHENOTHIAZINES].

Authors:  A RODOVA; K NAHUNEK
Journal:  Cesk Psychiatr       Date:  1964-08

3.  Side effects and laboratory findings during combined drug therapy of chronic schizophrenics.

Authors:  E M CAFFEY; C J KLETT
Journal:  Dis Nerv Syst       Date:  1961-07

4.  WEIGHT CHANGE DURING AND AFTER HOSPITAL TREATMENT.

Authors:  H L GORDON; C GROTH
Journal:  Arch Gen Psychiatry       Date:  1964-02

5.  Weight as a correlate of clinical response to psychotropic drugs.

Authors:  M M Singh; L V De Dios; N S Kline
Journal:  Psychosomatics       Date:  1970 Nov-Dec       Impact factor: 2.386

6.  The significance of brain damage in persistent oral dyskinesia.

Authors:  H Edwards
Journal:  Br J Psychiatry       Date:  1970-03       Impact factor: 9.319

7.  Thiothixene in young disturbed children. A pilot study.

Authors:  M Campbell; B Fish; T Shapiro; A Floyd
Journal:  Arch Gen Psychiatry       Date:  1970-07

8.  Epidemiology of infantile autism.

Authors:  D A Treffert
Journal:  Arch Gen Psychiatry       Date:  1970-05

9.  Ocular changes due to phenothiazine derivatives--a surgey.

Authors:  D J Wilson
Journal:  Trans Ophthalmol Soc U K       Date:  1970

10.  Ocular side effects of chlorpromazine in a child.

Authors:  L A Geiger; L L Lesser
Journal:  JAMA       Date:  1967-11-27       Impact factor: 56.272

View more
  9 in total

1.  Neurochemistry of withdrawal emergent symptoms in children.

Authors:  B G Winsberg; M J Hurwic; J Sverd; A Klutch
Journal:  Psychopharmacology (Berl)       Date:  1978-03-01       Impact factor: 4.530

2.  Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Markus Mittendorf; Frank M Theisen; Karin Wolf-Ostermann; Phillip Grant; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-04-28       Impact factor: 4.785

3.  Prevalence of self-injurious behaviors in a large state facility for the retarded: a three-year follow-up study.

Authors:  S R Schroeder; C S Schroeder; B Smith; J Dalldorf
Journal:  J Autism Child Schizophr       Date:  1978-09

4.  Neurological consequences of psychotropic drug withdrawal in schizophrenic children.

Authors:  P Polizos; D M Engelhardt; S P Hoffman; J Waizer
Journal:  J Autism Child Schizophr       Date:  1973 Jul-Sep

Review 5.  Use of drugs in child psychiatry.

Authors:  P Sitholey
Journal:  Indian J Pediatr       Date:  1984 Jul-Aug       Impact factor: 1.967

6.  Tardive dyskinesia and pregnancy and delivery complications.

Authors:  M H El-DeFrawi; G Hirsch; A Jurkowicz; T J Craig
Journal:  Child Psychiatry Hum Dev       Date:  1996

Review 7.  Infantile autism and the temporal lobe of the brain.

Authors:  B E Hetzler; J L Griffin
Journal:  J Autism Dev Disord       Date:  1981-09

Review 8.  Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

9.  Clinical aspects of dyskinesia.

Authors:  J Ananth
Journal:  Indian J Psychiatry       Date:  1980-07       Impact factor: 1.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.